Course #24D10: A Case Study on the Evolution of Delusional Beliefs & The Use of an Anti-inflammatory Diet as a Non-pharmacological Intervention in Depression Treatment- 2/29/2024

Thursday, February 29, 2024, 6:30 PM - 8:30 PM, Zoom Videoconference, Oklahoma City, OK

In this regularly scheduled series, four quarterly meetings with 2 hours of CME each will integrate course content to increase physicians' awareness of the broad cultural context of their patients. The presentations will enhance physicians' incorporation of this knowledge into an effective treatment plan that includes up-to-date evidence-based biological and psychotherapeutic treatments in culturally sensitive patient care. Methods and content include patient case studies, sessions focused on the interface of medical conditions (such as cancer or COVID-19) with psychiatric problems, presentations focusing on evidence-based treatments, and panels to increase physician leadership and address needs of the mentally ill in Oklahoma. A special focus on the opioid epidemic will assist psychiatrists in addressing these common problems in their patients.

Download Announcement

"A Case Study on the Evolution of Delusional Beliefs:
From Persecutory Delusions to Capgras Syndrome-Like Phenomena”
- - - - - - - - - - - - - - - - - - - -
Presented by:
 Ahmed Mohammed, MD 
PGY-2, Griffin Memorial Hospital
Psychiatric Residency Training Program, Norman

Professional Practice Gaps: This presentation will highlight diagnostic challenges in psychiatry beginning with the initial misdiagnosis of the patient to the final accurate diagnosis of psychiatric disorders. The presentation underscores the importance of through psychiatric assessments, considering the complexity of symptoms ad potential for underlying psychiatric conditions.

Learning Objectives: Upon completion of this session, participants will improve their competence and performance by being able to: (1) explore and analyze the patient's psychosocial background and traumatic history, focusing on how past verbal abuse, controlling behavior, and experiences may contribute to Capgras delusion development and (2) discuss medical complications, specifically hyperammonemia due to Depakote toxicity, during the inpatient stay with a view to emphasizing the significance of a multidisciplinary approach in managing psychiatric cases with medical complications.

“The Use of an Anti-inflammatory Diet as a Non-pharmacological Intervention in Depression Treatment”
- - - - - - - - - - - - - - - - - - - -
Presented by:
 Cree Clay, MD 
PGY-4, University of Oklahoma Health Sciences Center
Psychiatric Residency Training Program, Oklahoma City
 
Professional Practice Gaps: This presentation will highlight the significance of an Anti-Inflammatory Diet in the treatment of Major Depressive Disorder in comparison to the Standard American Diet and will provide suggestions on how to incorporate this information into your daily practice in regards to patient care.

Learning Objectives:  Upon completion of this presentation, participants will improve their competence and performance by being able to: (1) Determine the difference between an Anti-Inflammatory and Inflammatory Diet; (2) Provide a non-pharmacological intervention in Depression Treatment to Psychiatric patients; and (3) Explain the pathways of Inflammation leading to Chronic Illness.

1. Explore and analyze the patient's psychosocial background and traumatic history, focusing on how past verbal abuse, controlling behavior, and experiences may contribute to Capgras delusion development
2. Discuss medical complications, specifically hyperammonemia due to Depakote toxicity, during the inpatient stay with a view to emphasizing the significance of a multidisciplinary approach in managing psychiatric cases with medical complications.
3. Determine the difference between an Anti-Inflammatory and Inflammatory Diet
4. Provide a non-pharmacological intervention in Depression Treatment to Psychiatric patients
5. Explain the pathways of Inflammation leading to Chronic Illness.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Oklahoma College of Medicine and the Central Oklahoma Psychiatric Society (COPS). The University of Oklahoma College of Medicine is accredited by the ACCME to provide continuing medical education for physicians

The University of Oklahoma College of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation Statement: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

University of Oklahoma Equal Opportunity / Non-Discrimination Statement: The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, housing, services in educational programs or activities, or health care services that the university operates or provides.
 
To file a grievance related to the non-discrimination policy, report sexual misconduct, and/or file a formal complaint of sexual misconduct, please utilize the reporting form at link.ou.edu/reportingform.
 
Inquiries regarding non-discrimination policies may be directed to the Office(s) of Institutional Equity as may be applicable – Norman campus: (405) 325-3546/3549, Health Sciences Center: (405) 271-2110, or OU-Tulsa Title IX Office: (918) 660-3107. Additionally, individuals may visit www.ou.edu/eoo.

Accommodation Statement:  Accommodations on the basis of disability are available by contacting Maggie Montgomery at (405) 360-5066 or [email protected] as soon as possible.

Disclaimer Statement:  Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty, Joint Provider and Presenters Disclosure: 
It is the policy of the University of Oklahoma, College of Medicine that the faculty, presenters and joint provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).  

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Attendance (2.00 hours)

Mitigation of Relevant Financial Relationships

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

This activity received no commercial or in-kind support.